Multiple Assemblies exist for SMTL entry 7f3v
Crystal structure of YfiH with C107A mutation in complex with endogenous UDP-MurNAc; X-RAY DIFFRACTION 1.47 Å

	SMTL ID 7f3v.1 Ligands (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid; PHOSPHATE ION Polypeptides Purine nucleoside phosphorylase YfiH Oligo-state monomer
	SMTL ID 7f3v.2 Ligands (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid; PHOSPHATE ION Polypeptides Purine nucleoside phosphorylase YfiH Oligo-state monomer
	SMTL ID 7f3v.3 Ligands (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid; 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL Polypeptides Purine nucleoside phosphorylase YfiH Oligo-state monomer
	SMTL ID 7f3v.4 Ligands (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid; 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL Polypeptides Purine nucleoside phosphorylase YfiH Oligo-state monomer